A total of 100 patient charts were reviewed; 70 patients in the tobacco plus marijuana group and 30 in the tobacco only group. There were significant differences in clinical course and outcomes between the two groups with poorer outcomes noted in tobacco plus marijuana smokers (p < .001).
INTRODUCTION
Physicians at St Lucia's general hospitals have noted a steady increase in the number of young patients admitted with severe Chronic Obstructive Pulmonary Disease (COPD) and its complications. Both hospitals have raised the concern that patients who smoke tobacco mixed with marijuana seem to develop and die from COPD and its complications at a significantly younger age than tobacco only smokers. The smoking of marijuana mixed with tobacco is a common practice among the youth in St Lucia and further study is required to investigate the adverse effects of combined marijuana and tobacco smoking in this patient population. Tan et al observed that smoking both tobacco and marijuana synergistically increased the risk of respiratory symptoms and COPD 1 .
Tan's Vancouver population based study suggested that concurrent use of tobacco and marijuana was associated with an increased risk of respiratory symptoms and COPD if the lifetime dose of marijuana exceeded 50 marijuana cigarettes. This increased risk is consistent with the trend of earlier onset of chronic lung disease in our population and underscores the need for further research to better assess the relationship between combined tobacco plus marijuana use and chronic lung disease in our patients. This study could inform future public health interventions aimed at decreasing the health burden of Chronic Obstructive Pulmonary Disease in St Lucia and other countries.
SUBJECTS AND METHODS
A retrospective cohort study was used to investigate patients admitted to the Victoria and St Jude (2), concomitant use of cocaine (11) and valvular heart disease (1). Of the remaining 100 patients included in the study 70 reported smoking tobacco plus marijuana and 30 reported smoking tobacco only.
Measurements and definitions
Patient charts were reviewed by the principal investigator for select biographic information, substance use, clinical course and adverse outcomes related to COPD including death. Cumulative tobacco exposure was calculated in "pack years" with one pack year defined as smoking one pack of 20 cigarettes per day for one year. Cumulative marijuana exposure was calculated in "joint years" with one joint year defined as smoking one joint per day for one year.
Eighty percent of tobacco plus marijuana smokers mixed the two substances into a single joint or "tobacco spliff". The most common ratio of tobacco to marijuana in mixed joints was 1:4 with five mixed joints having the equivalent of 0.7 grams of tobacco or one tobacco cigarette.
Cumulative tobacco pack year calculations included the tobacco content of mixed joints. Charts were reviewed to validate the diagnosis of cor pulmonale and ensure consistency in application of criteria for the diagnosis. Cor pulmonale was defined as clinical evidence of right heart failure, and/or chest x-ray evidence of pulmonary hypertension/right heart enlargement. Chest x-ray evidence for a diagnosis of cor pulmonale was independently confirmed by a board certified consultant radiologist. Echocardiograms were used to confirm the diagnosis where available.
Patient chart review and death certificates were used to determine whether COPD and its complications were significant contributors to or causes of mortality.
Statistical analysis
All analyses were performed using IBM SPSS Statistics version 22. Levene's test was initially applied to assess the equality of variance in our study population; followed by independent samples t-Test to compare differences in mean values between the two groups. Odds ratios (OR) with 95%
confidence intervals (CI) were calculated for associations between substance use and cor pulmonale and cor pulmonale and death. 
RESULTS

Tobacco only smokers
Thirty patients reported smoking tobacco only, 23 males and 7 females, with a mean age of 72.6 years (SD = 11.6) at first admission for COPD. The mean tobacco pack year history was 34 (SD 29). Cor pulmonale was diagnosed in 2 of the 30 patients in this group. There were 8 deaths in this group with cancer of the respiratory tract being the most common cause of mortality (3 patients) 37.5% of deaths. One patient death was secondary to COPD with cor pulmonale.
Comparative analysis
Two thirds of tobacco plus marijuana smokers required admission for COPD prior to the age of 50 as compared to none in the tobacco only group. The mean age at first admission for tobacco plus marijuana smokers was significantly younger (Fig. 1 Cor Pulmonale was a significant cause of morbidity and mortality among tobacco plus marijuana smokers as compared to tobacco only smokers. Fifty three percent (53%) of tobacco plus marijuana smokers were diagnosed with cor pulmonale compared to 6% of tobacco only smokers (OR 15.7, 95% CI 3.47-71.01). Cor pulmonale also contributed significantly to mortality in tobacco plus marijuana smokers with right heart failure as a listed complication in 23 of the 26 deaths (88%) compared to 1 of the 8 deaths (12.5%) in the tobacco only group. Patients who smoked tobacco and marijuana died at a younger age (Fig. 2) , median age at time of death 47.6 years (SD = 7.2) versus 73.6 years (SD = 12.8) for tobacco only smokers (p < 0.001). 
DISCUSSION
The results of our retrospective cohort study show worse clinical outcomes for patients admitted with COPD who smoke both tobacco and marijuana as compared with tobacco only. There is a growing body of evidence to suggest that individuals who smoke both tobacco and marijuana are at a greater risk for respiratory symptoms or COPD when compared with those who smoke tobacco only (1) (2) (3) . However previous studies have primarily investigated outpatient populations through general practice clinics and population based census activities (1) (2) (3) . Our study demonstrated an earlier onset of pulmonary disease and an increased risk for the development of cor pulmonale in patients hospitalized with COPD who smoke both tobacco and marijuana as compared with tobacco only (p < 0.001).
Strengths and limitations
The reliance on chart reviews for substance use histories required certain assumptions to be made; based on common practices e.g. tobacco to marijuana ratios in mixed joints. Black tobacco is used regularly in mixed joints and further investigation is required to delineate risks specific to black tobacco versus regular tobacco. The number of marijuana only smokers was inadequate to serve as a control group; thus limiting our ability to assess for clinically significant respiratory disease in marijuana only smokers.
CONCLUSION
This study demonstrated worse clinical outcomes for tobacco smokers who also smoke marijuana.
In addition to an increased risk of earlier onset of moderate to severe COPD requiring admission, there was an increased risk of progression to cor pulmonale and death when compared to tobacco only smokers. Despite these poorer outcomes, cumulative tobacco consumption was lower in tobacco plus marijuana smokers as compared to tobacco only smokers. This is suggestive of a synergistic effect between tobacco and marijuana, as cited in earlier studies (1).
The significant morbidity and mortality risk seen in our study among patients who mix tobacco and marijuana highlights the need for further research into the mechanisms of early disease progression. This could allow for more targeted treatment and informed clinical advice for our Clinical Outcomes in Tobacco and Marijuana Smokers with COPD 10 patients. Future public education campaigns would not only encourage tobacco cessation; but might also discourage the mixing of tobacco with marijuana.
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